Status:
COMPLETED
Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Myomectomy
Eligibility:
FEMALE
18-50 years
Phase:
PHASE4
Brief Summary
To evaluate the effects of oxytocin infusion during abdominal myomectomy.
Detailed Description
Myomectomy is indicated for symptomatic uterine fibroids. Fibroids have blood supply and 20% of the abdominal myomectomy cases might require blood transfusion because of the nature of the surgery. Oxy...
Eligibility Criteria
Inclusion
- Age 18-50
- Patients who are candidate for abdominal myomectomy
Exclusion
- History of previous myomectomy.
- Suspected malignancy
- Patients with preoperative anemia
- Patients using hormonal treatments before the surgery.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03308643
Start Date
October 1 2017
End Date
May 10 2018
Last Update
May 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanuni Sultan Suleyman Egitim ve Arastırma Hastanesi
Istanbul, Turkey (Türkiye)